Multiple Sclerosis Clinical Trial
Next-Gen MS: Feed-forward PRO Data for MS Research
Summary
This Next Generation learning health system for Multiple Sclerosis (Next-Gen MS) study is a sub-study of the MS-LINK™ Outcomes Study (NCT04735406). The study aims to examine the effects of using feed forward Patient Reported Outcomes (PROs) data in real-world Multiple Sclerosis (MS) care settings. The study will be conducted within an emerging Learning Healthcare System (LHS).
View Eligibility Criteria
Eligibility Criteria
Inclusion Criteria:
Participants willing and able to provide written informed consent
Participants with clinical diagnosis of Multiple Sclerosis (MS)
Exclusion Criteria:
None
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
Submit
There are 8 Locations for this study
See Locations Near You
Alabama Neurology Associates
Birmingham Alabama, 35209, United States
Birmingham Alabama, 35209, United States
Georgetown University
Washington District of Columbia, 20057, United States
Washington District of Columbia, 20057, United States
Atlanta Neuroscience Institute
Atlanta Georgia, 30327, United States
Atlanta Georgia, 30327, United States
Beth Israel Deaconess Medical Center
Boston Massachusetts, 02215, United States
Boston Massachusetts, 02215, United States
The Memorial Hospital, d.b.a Memorial Healthcare
Owosso Michigan, 48867, United States
Owosso Michigan, 48867, United States
Oklahoma Medical Research Foundation
Oklahoma City Oklahoma, 73104, United States
Oklahoma City Oklahoma, 73104, United States
The University of Texas of Austin
Austin Texas, 78759, United States
Austin Texas, 78759, United States
The University of Texas Health Science Center
San Antonio Texas, 78229, United States
San Antonio Texas, 78229, United States
How clear is this clinincal trial information?